Product Spotlight - Crodamol™ CCC Pharma
Crodamol™ CCC Pharma is a mild, non-irritating liquid emollient, ideal for sensitive site applications. The excipient can contribute to many benefits for various topical formulations.
• Enhances dermal permeation of many APIs
• Non-irritating liquid emollient
• Ideal for sensitive skin applications
• Appealing sensory properties
• Suitable for emulsions, ointments, gels and foams
• Practically insoluble in water, miscible with alcohol and liquid paraffin.
Key benefits of Crodamol CCC Pharma:
• Monograph compliant – Ph. Eur.• Enhances dermal permeation of many APIs
• Non-irritating liquid emollient
• Ideal for sensitive skin applications
• Appealing sensory properties
• Suitable for emulsions, ointments, gels and foams
• Practically insoluble in water, miscible with alcohol and liquid paraffin.
Our extensive experience in skin science has led to the development of innovative ingredients that enhance the efficacy and patient perception of topical pharmaceuticals. Our topical excipients include drug delivery systems, skin penetration enhancers, solubilisers, emulsifiers and emollients.
.jpg&mn=healthcare&w=768&xr=0&yr=0&xfp=6&yfp=6&hash=CC2ED77A6E51ACA367EE7726DC83D78619C138999FEC74AA)
Crodamol™ CCC pharma
Cocoyl caprylocaprate is used in topical formulations. It is a non-irritating liquid ideal for sensitive site applications. The excipient can contribute to many benefits for various topical systems...
Explore the Crodamol™ range:
26 items available
.jpg&mn=healthcare&w=768&xr=0&yr=0&xfp=6&yfp=6&hash=7875B5CADE04723B83FD68B6A98A3C4619C138999FEC74AA)
Crodamol™ DA pharma
Diisopropyl adipate (DIPA) is a multifunctional light, non-occlusive, non-oily emollient. Its very low viscosity results in excellent spreading properties, rapid absorbency and low residual tack on the...
Crodamol™ IPM
Pharmaceutical grade of isopropyl myristate. Solvent used in topical formulations to encourage rapid absorption into skin. Required HLB value of 10. Recommended topical usage levels of 0.5-5%.
Crodamol™ CCC pharma
Cocoyl caprylocaprate is used in topical formulations. It is a non-irritating liquid ideal for sensitive site applications. The excipient can contribute to many benefits for various topical systems such...
.jpg&mn=healthcare&w=768&xr=0&yr=0&xfp=6&yfp=6&hash=B7A014F4ED7B52AFF22F83F2BEDE8A5919C138999FEC74AA)
Crodamol™ EO pharma
Low viscosity solvent for lipophilic actives. Rapidly absorbed by body tissues. Dermal penetration enhancer. Required HLB value of 11. Recommended topical usage levels of 0.5-5%.
.jpg&mn=healthcare&w=768&xr=0&yr=0&xfp=6&yfp=6&hash=FB4D8C3DB541E2E8715598FA9EDF66D519C138999FEC74AA)
Crodamol™ IPIS pharma
Crodamol IPIS is a liquid, non-ionic emollient with light and easy spreading characteristics for use in topical formulations. It also provides outstanding moisturisation with appealing sensory to improve...
Crodamol™ ISIS pharma
DMF ready, this substantive non-occlusive emollient provides superior moisturisation to the skin. It has been shown to synergistically improve the skin's natural barrier function, boosting the hydration...
Crodamol™ ICS
Low viscosity branched chain emollient with high spreading capacity. Required HLB value of 8. Recommended topical usage levels of 2-15%.
Crodamol™ IPP pharma
Pharmaceutical grade of isopropyl palmitate. An easy spreading, non-occlusive dry emollient. Required HLB value of 10. Recommended topical usage levels of 0.5-5%.
Crodamol™ GTCC pharma
Solubiliser and carrier for oil soluble actives. Nutritional source of lipids for medicinal foods. Good emollient with excellent oxidative stability. Filler in capsules and tablets. Lubricant for gelatin...
Crodamol™ GMCC pharma
The ingredient acts as an excellent solvent for many organic compounds, including steroids. The ingredient works as a solvent of the API in a soft gelatin capsule and is commonly used in nutritional &...
Crodamol™ AB pharma
Light non-greasy emollient with excellent solvency and spreading properties. Required HLB of 12. Recommended topical usage levels of 0.5-5%. For more information on product availability manufactured in...
Crodamol™ CP pharma
Dry emollient. Improves emulsion texture and stability. Required HLB value of 9. Recommended topical usage levels of 1-5%.
Crodamol™ PC pharma
Low viscosity solvent with good spreading properties. Skin penetration enhancer. Vehicle for anti-parasitic pour-ons. Required HLB value of 8. Recommended topical usage levels of 2-10%.
Crodamol™ SS pharma
Emollient and bodying agent for creams and ointments. A substitute of non-animal origin for spermaceti wax. Required HLB value of 7 (70°C). Recommended topical usage levels of 0.5-10%.
Crodamol™ STS
Provides silicone-like feel with superior emulsion formation and stability. Effective wetting agent for pigments. Provides enhanced wash-off resistance in creams and lotions. Required HLB value of 9. Recommended...
Crodamol™ PMP
Low viscosity solvent with excellent spreading properties. Light textured emollient which reduces greasiness of formulations. Vehicle for anti-parasitic pour-ons. Required HLB value of 9. Recommended topical...
Crodamol™ OPG
Branched chain structure provides excellent spreading capacity. Effective wetting agent. Required HLB value of 10. Recommended topical usage levels of 2-5%.
Crodamol™ OHS
Rich, persistent branched chain emollient with a high viscosity. Required HLB value of 12. Recommended topical usage levels of 0.5-10%.
Crodamol™ OC
Branched chain emollient ester developed specially for personal care and pharmaceutical applications. Non-occlusive, branched chain, fine emollient. Helps to reduce film tackiness.
Crodamol™ OP
Excellent moisturiser with low comedogenicity. Branched chain, light, non-greasy oil. Suitable for use in facial and body products. Good mineral oil alternative. Required HLB value of 8. Recommended topical...
Crodamol™ ML
Versatile emollient with good solubility in aqueous alcoholic and glycol solutions. Imparts velvety skin feel when used in topical formulations. Liquefies at skin surface temperature offering a perceived...
Crodamol™ GTEH
Light and elegant skin feel with good spreadability. Gives dry lubrication with exceptional skin coverage. Recommended topical usage levels of 0.5-5%.
Crodamol™ MM
Dry emollient feel. Improves emulsion texture and stability. Bodying agent. Required HLB value of 8 (70°C). Recommended topical usage levels of 3-10%.
Crodamol™ CAP
Branched chain ester with excellent spreading properties. Vehicle in pour-on endectocides for veterinary applications. Required HLB value of 8. Recommended topical usage levels of 2-10%.
Crodamol™ PTIS
Rich, non comedogenic emollient with low spreading capacity and high viscosity. Water repellent. Good alternative to castor oil for skin creams and lotions. Required HLB value of 7. Recommended topical...
Crodamol™ SFX
Crodamol SFX is a patented emollient ester possessing many of the sensory benefits of cyclomethicone D5. Crodamol SFX can be used to enhance the aesthetics of a wide range of topical products and acts...
PRODUCT USE CASE STUDY
Emugel formulation: "We need a light-feeling gelled emulsion to offer rapid pain relief"
Technical barriers:
- We need a formulation that can easily spread and be absorbed into the skin
- We need to increase the speed of pain relief.
Solutions:
- Crodamol™ CCC Pharma easily absorbs into the skin, leaving minimal residue and fast rub in
- Crodamol CCC Pharma has been shown to increase the release of actives in topical formulations
- Emulsifiers Arlacel™ LC and Volarest™ FL allow minimal residue for the formulation, making in rub in fast and grease free.
After formulating with Crodamol™ CCC, the customer was able to make the following pack claims:
- Quick absorbing
- Faster release
- Light feel.
Did you know Volarest™ FL and Arlacel™ LC can be used in combination to make a “spray on emulgel?”
Explore recent blogs:
Heart Health month
February marks Heart Month, this global initiative looks to educate the population on heart disease and what preventative measures can be taken to improve cardiovascular health. In this blog, we...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=51D19B4B65B031475D93DBD45F1F23DC)
Insights into the veterinary health market
The veterinary market in the EMEA region is expected to experience substantial growth in the coming years: 5-8% CAGR. Typically, the veterinary market is categorised into companion animals and...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=D964AC649BA30C623822E347ADA7FD18)
World Cancer Day 2025
In 2022 alone, 9.7 million people worldwide lost their lives to cancer, and the number of new cases is expected to rise to nearly 30 million by 2040. It is a disease that takes so much from so many,...